Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Meningococcal Vaccine by Serotype
5.1 Mena Vaccine
5.1.1 Market Size and Forecast
5.2 Menac Vaccine
5.2.1 Market Size and Forecast
5.3 Menacyw Vaccine
5.3.1 Market Size and Forecast
5.4 Menb/Bc Vaccine
5.4.1 Market Size and Forecast
5.5 Menc Vaccine
5.5.1 Market Size and Forecast

Part 6. Global Market for Meningococcal Vaccine by Vaccine Type
6.1 Conjugate Meningococcal Vaccines
6.1.1 Market Size and Forecast
6.2 Polysaccharide Vaccine
6.2.1 Market Size and Forecast
6.3 Subcapsular Vaccines
6.3.1 Market Size and Forecast

Part 7. Global Market for Meningococcal Vaccine by End User
7.1 Adults
7.1.1 Market Size and Forecast
7.2 Pediatrics
7.2.1 Market Size and Forecast
7.3 Travelers
7.3.1 Market Size and Forecast

Part 8. Global Market for Meningococcal Vaccine by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles
9.1 GlaxoSmithKline Plc.
9.2 Hualan Biological Engineering Inc.
9.3 Pfizer inc.
9.4 Sanofi S.A.
*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY